BIPIX
ProFunds Biotechnology UltraSector Fund Investor Class
1W: -0.5%
1M: -10.1%
3M: -7.1%
YTD: +36.6%
1Y: +77.2%
3Y: +142.8%
5Y: +71.9%
$91.35
-0.10 (-0.11%)
Weekly Expected Move ±5.2%
$82
$87
$91
$96
$101
ETF-Level Metrics
AUM$356M
Holdings146
Top 10 Wt11.8%
Beta1.60
% Profitable20%
Coverage71%
Portfolio Valuation
P/E37.5
P/B5.7
P/S6.4
EV/EBITDA25.2
P/FCF24.1
PEG2.36
Profitability & Returns
Gross Margin84.7%
Net Margin-1.1%
ROE-1.0%
ROA-0.4%
ROIC8.8%
Div Yield0.12%
Leverage & Liquidity
Debt/Equity0.93
Debt/Assets0.37
Net Debt/EBITDA1.3x
Interest Cov4.3x
Current Ratio1.72
Quick Ratio1.52
Growth (YoY)
Revenue+35.8%
Net Income-2.8%
EPS+6.7%
FCF+5.5%
EBITDA+4.2%
Rev CAGR 3Y+62.4%
Quality Scores
Piotroski F3.8
Altman Z16.77
IS Quality52.0
IS Overall44.4
IS Value37.1
Median P/E-6.0
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 143 | 71.3% | -10.6 |
| Other | 11 | 27.9% | — |
| Financial Services | 3 | 3.0% | 10.4 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 157 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | N/A Private | — | 8.47% | $15.5M | 15,471,000 | — | — | — |
| 2 | N/A Private | — | 7.20% | $13.2M | 13,150,000 | — | — | — |
| 3 | N/A Private | — | 6.36% | $11.6M | 11,603,000 | — | — | — |
| 4 | N/A Private | — | 4.24% | $7.7M | 7,735,000 | — | — | — |
| 5 | N/A Private | — | 2.11% | $3.8M | 3,847,000 | — | — | — |
| 6 | AGPXX | AGPXX | 2.05% | $3.7M | 3,746,290 | — | $79.1B | Financial Services |
| 7 | N/A Private | — | 1.48% | $2.7M | 2,707,000 | — | — | — |
| 8 | APELLIS PHARMACEUTICALS INC | APLS | 1.35% | $2.5M | 60,117 | 38.7 | $5.3B | Healthcare |
| 9 | REVOLUTION MEDICINES INC | RVMD | 1.19% | $2.2M | 15,087 | -23.3 | $43.9B | Healthcare |
| 10 | TRAVERE THERAPEUTICS INC | TVTX | 1.17% | $2.1M | 50,777 | -126.5 | $5.3B | Healthcare |
| 11 | ARROWHEAD PHARMACEUTICALS INC | 0HI3.L | 1.04% | $1.9M | 25,860 | -28.7 | $9.0B | Healthcare |
| 12 | TWIST BIOSCIENCE CORP | TWST | 1.03% | $1.9M | 32,063 | -85.0 | $11.7B | Healthcare |
| 13 | SUMMIT THERAPEUTICS INC | SMMT | 1.01% | $1.9M | 86,301 | -15.0 | $13.4B | Healthcare |
| 14 | ALKERMES PLC | ALKS | 1.00% | $1.8M | 54,105 | 103.6 | $7.0B | Healthcare |
| 15 | TG THERAPEUTICS INC | 0VGI.L | 0.99% | $1.8M | 53,565 | 17.8 | $8.1B | Healthcare |
| 16 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.99% | $1.8M | 3,482 | -38.7 | $11.5B | Healthcare |
| 17 | BEAM THERAPEUTICS INC | BEAM | 0.96% | $1.7M | 57,611 | -29.9 | $2.5B | Healthcare |
| 18 | APOGEE THERAPEUTICS INC | APGE | 0.91% | $1.7M | 20,119 | -31.1 | $8.4B | Healthcare |
| 19 | SCHOLAR ROCK HOLDING CORP | SRRK | 0.89% | $1.6M | 34,796 | -14.1 | $5.6B | Healthcare |
| 20 | PRAXIS PRECISION MEDICINES INC | PRAX | 0.88% | $1.6M | 5,059 | -22.8 | $8.2B | Healthcare |
| 21 | EXELIXIS INC | EX9.DE | 0.88% | $1.6M | 35,988 | 17.7 | $9.2B | Healthcare |
| 22 | MIRUM PHARMACEUTICALS INC | MIRM | 0.87% | $1.6M | 16,376 | -5.7 | $5.1B | Healthcare |
| 23 | UNITED THERAPEUTICS CORP | UTHR | 0.86% | $1.6M | 2,758 | 17.9 | $23.0B | Healthcare |
| 24 | NATERA INC | NTRA | 0.86% | $1.6M | 7,642 | -301.7 | $58.8B | Healthcare |
| 25 | CRISPR THERAPEUTICS AG | CRSP | 0.86% | $1.6M | 30,092 | -11.6 | $5.3B | Healthcare |
| 26 | CELCUITY INC | CELC | 0.86% | $1.6M | 12,979 | -16.8 | $3.5B | Healthcare |
| 27 | KRYSTAL BIOTECH INC | KRTA.F | 0.85% | $1.5M | 5,892 | 10.4 | $2.2B | Financial Services |
| 28 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.84% | $1.5M | 15,573 | 115.0 | $9.0B | Healthcare |
| 29 | NEUROCRINE BIOSCIENCES INC | 0K6R.L | 0.84% | $1.5M | 11,599 | 20.3 | $14.3B | Healthcare |
| 30 | INCYTE CORP | 0J9P.L | 0.83% | $1.5M | 15,873 | 14.2 | $22.8B | Healthcare |
| 31 | CG ONCOLOGY INC | CGON | 0.83% | $1.5M | 22,645 | -25.0 | $5.9B | Healthcare |
| 32 | CYTOKINETICS INC | CYTK | 0.83% | $1.5M | 23,613 | -9.1 | $8.2B | Healthcare |
| 33 | NUVALENT INC | NUVL | 0.82% | $1.5M | 15,017 | -20.5 | $9.1B | Healthcare |
| 34 | IONIS PHARMACEUTICALS INC | 0JDI.L | 0.82% | $1.5M | 20,089 | -12.6 | $7.1B | Healthcare |
| 35 | BRIDGEBIO PHARMA INC | BBIO | 0.82% | $1.5M | 21,046 | -18.8 | $13.2B | Healthcare |
| 36 | VAXCYTE INC | PCVX | 0.82% | $1.5M | 26,117 | -7.4 | $8.2B | Healthcare |
| 37 | KYMERA THERAPEUTICS INC | KYMR | 0.82% | $1.5M | 18,431 | -33.0 | $8.8B | Healthcare |
| 38 | BIOGEN INC | BIIB.SW | 0.82% | $1.5M | 7,888 | 30.0 | $20.8B | Healthcare |
| 39 | COGENT BIOSCIENCES INC | COGT | 0.82% | $1.5M | 41,643 | -13.4 | $5.3B | Healthcare |
| 40 | PTC THERAPEUTICS INC | PTCT | 0.82% | $1.5M | 22,879 | -129.5 | $5.3B | Healthcare |
| 41 | INSMED INC | 0JAV.L | 0.80% | $1.5M | 10,778 | -27.0 | $23.7B | Healthcare |
| 42 | ALNYLAM PHARMACEUTICALS INC | 0HD2.L | 0.79% | $1.5M | 4,689 | 36.0 | $29.7B | Healthcare |
| 43 | ROIVANT SCIENCES LTD | ROIVW | 0.79% | $1.4M | 50,794 | -4.3 | $2.0B | Healthcare |
| 44 | HALOZYME THERAPEUTICS INC | 0J2O.L | 0.79% | $1.4M | 22,601 | 31.2 | $13.0B | Healthcare |
| 45 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.78% | $1.4M | 60,967 | 113.9 | $3.1B | Healthcare |
| 46 | SPYRE THERAPEUTICS INC | AGLE | 0.77% | $1.4M | 18,961 | -6.0 | $49M | Healthcare |
| 47 | SOLENO THERAPEUTICS INC | SLNO | 0.77% | $1.4M | 26,523 | 27.1 | $2.8B | Healthcare |
| 48 | ABBVIE INC | 4AB.DE | 0.76% | $1.4M | 6,599 | 74.0 | $408.1B | Healthcare |
| 49 | AMGEN INC | 4332.HK | 0.75% | $1.4M | 3,979 | — | $998.5B | Healthcare |
| 50 | REGENERON PHARMACEUTICALS INC | 0R2M.L | 0.75% | $1.4M | 1,940 | 17.6 | $79.6B | Healthcare |